Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME : Episode 1

Opinion

Video

July 10, 2024

Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and Diabetic Macular Edema

Author(s):

Hong-Uyen Hua, MD,Sruthi Arepalli, MD

A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.

EP: 1.Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and Diabetic Macular Edema

1:00 Suboptimal Response
6:30 Treatment Strategy
11:10 Response to New Therapies
14:00 Imaging for Monitoring
18:30 Role of Ang-2

Related Videos

Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas

Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital

Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates

Diana V. Do, MD: 3-Year PHOTON Data on Aflibercept 8 mg for DME | Image Credit: Stanford University

Eric W Schneider, MD: Comparing AI-Based Home OCT to In-Office OCT Scans | Image Credit: Tennessee Retina

Matthew Cunningham, MD: 1-Year ELEVATUM Results Target Disparities in DME | Image Credit: Florida Retina Institute

Psoriasis podcast

3 KOLs are featured in this series.

3 KOLs are featured in this series.

Dennis M. Marcus, MD , an expert on neovascular AMD

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.